A61P 15 - Drugs for genital or sexual disorders; Contraceptives

Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
12/2002
12/04/2002	CN1382694A Human testis development specific protein-17 gene coding protein
12/04/2002	CN1382465A 'Wugu' recovery ointment
12/04/2002	CN1382444A Viginal medicine for treating gynopathy
12/04/2002	CN1382440A Method and medicine case for treating depression or preventing degeneration of cognitive function
12/04/2002	CN1095380C Medicine for treating primary menalgia
12/04/2002	CN1095365C Method for raising sow conception, farrowing and survical rate by using vitamin E
12/03/2002	US6489353 Antiinflammatory agents; autoimmune diseases; central nervous system disorders
12/03/2002	US6489347 Process
12/03/2002	US6489344 For treatment diabetes in a human or animal subject
12/03/2002	US6489332 A1 adenosine receptor antagonists
12/03/2002	US6489296 Treatment of hypercoagulable states or acquired protein c deficiency with activated protein c, a highly selective therapeutic agent with a low potential for causing bleeding complications
12/03/2002	US6488953 Oral transmucosal delivery
12/03/2002	CA2213198C Gene therapy by anti-tgf-b agents
12/03/2002	CA2074933C Thiazole derivatives as active superoxide radical inhibitors
12/03/2002	CA2065644C Pyrazolopyridine compound and processes for preparation thereof
11/2002
11/28/2002	WO2002095410A1 Adherent entities and uses therefor
11/28/2002	WO2002095067A2 INTERFERON α-14 POLYMORPHISM
11/28/2002	WO2002094997A2 Transcriptional regulation of target genes
11/28/2002	WO2002094825A1 Novel spiropiperidine derivative
11/28/2002	WO2002094813A1 Novel pyridyl cyanoguanidine compounds
11/28/2002	WO2002094808A1 Imidazole-2-carboxamide derivatives as raf kinase inhibitors
11/28/2002	WO2002094799A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002	WO2002094788A1 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
11/28/2002	WO2002094379A1 Use and compositions of antiprogestins for treatment of prostate diseases
11/28/2002	WO2002094342A2 Compositions for protein delivery via the pulmonary route
11/28/2002	WO2002094281A1 Means and method for hormonal contraception
11/28/2002	WO2002094280A1 Means and method for hormonal contraception
11/28/2002	WO2002094279A1 Drug delivery system comprising a tetrahidroxilated estrogen for use in hormonal contraception
11/28/2002	WO2002094278A1 Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
11/28/2002	WO2002094277A1 Means and method for hormonal contraception
11/28/2002	WO2002094275A1 Use of estrogen compounds to increase libido in women
11/28/2002	WO2002094268A1 Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen
11/28/2002	WO2002094236A1 Delivery of antipsychotics through an inhalation route
11/28/2002	WO2002094186A2 Urazole compounds useful as anti-inflammatory agents
11/28/2002	WO2002085897A8 Heterocyclic compounds for aging-related and diabetic vascular complications
11/28/2002	WO2002080887A3 Timed pulse release composition
11/28/2002	WO2002079408A3 Short bioactive peptides and methods for their use
11/28/2002	WO2002072631A8 Mhc molecule constructs and their usesfor diagnosis and therapy
11/28/2002	WO2002070563A3 Nuclear hormone receptor ligand binding domain
11/28/2002	WO2002035235A3 Net as regulator of angiogenic expression
11/28/2002	WO2002024924A3 Protein phosphatases
11/28/2002	WO2002008255A3 Cell cycle proteins and mitosis-associated molecules
11/28/2002	WO2001096393A9 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
11/28/2002	WO2001089497A3 Praziquantel compositions for treating diseases due to sarcocystis, neospora, toxoplasma and isospora
11/28/2002	WO2001018021A9 B7-like polynucleotides, polypeptides, and antibodies
11/28/2002	US20020178459 Genetically engineered mammal for use in the treatment of muscle and liver disorders
11/28/2002	US20020178135 Image searching system and image searching method, and a recording medium storing an image searching program
11/28/2002	US20020177689 Compounds for the treatment of sexual dysfunction
11/28/2002	US20020177626 Comprises analgesics such as ibuprofen and diphenhydramine; storage stability
11/28/2002	US20020177618 ERK (extracellular signal regulated kinase) inhibitors for treatment of cancer, inflammatory disorders, restenosis, and cardiovascular disease
11/28/2002	US20020177609 Fatty alcohol drug conjugates
11/28/2002	US20020177599 Cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP PDE5) inhibitors; 2-(5-Acetyl-2-butoxy-3-pyridinyl)-7-ethyl-5-methylimidazo(5,1 -f)(1,2,4)triazin-4(3H)-one for example
11/28/2002	US20020177587 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
11/28/2002	US20020177545 Compositions and methods for treating gonadotrophin related illnesses
11/28/2002	US20020177213 Tissue plasminogen activator-like protease
11/28/2002	CA2448280A1 Means and method for hormonal contraception
11/28/2002	CA2448271A1 Means and method for hormonal contraception
11/28/2002	CA2448270A1 Means and method for hormonal contraception
11/28/2002	CA2448080A1 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002	CA2448022A1 Compositions for protein delivery via the pulmonary route
11/28/2002	CA2447940A1 Urazole compounds useful as anti-inflammatory agents
11/28/2002	CA2447215A1 Adherent entities and uses therefor
11/28/2002	CA2444787A1 Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen
11/27/2002	EP1260519A1 Membrane receptors for steroids and sterols
11/27/2002	EP1260225A1 A pharmaceutical composition for use in hormone replacement therapy
11/27/2002	EP1259544A2 Heterologous polypeptide of the tnf family
11/27/2002	EP1259527A1 35 human secreted proteins
11/27/2002	EP1259523A2 Pluraflavins and derivatives thereof, process for their preparation and use thereof
11/27/2002	EP1259514A2 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/27/2002	EP1259510A2 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
11/27/2002	EP1259505A2 Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
11/27/2002	EP1259504A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents
11/27/2002	EP1259494A1 Aryloxyacetic acids for diabetes and lipid disorders
11/27/2002	EP1259491A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates and amides and their use as alpha-1a agonists
11/27/2002	EP1259488A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
11/27/2002	EP1259481A1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same
11/27/2002	EP1259292A2 Therapeutic agents
11/27/2002	EP1259243A2 Bupropion metabolites and methods of their synthesis and use
11/27/2002	EP1259229A2 Use of pde v inhibitors
11/27/2002	EP1259223A1 Protein matrix materials, devices and methods of making and using thereof
11/27/2002	EP1192152B1 Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof
11/27/2002	EP1089742B1 Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein
11/27/2002	EP1000048B1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
11/27/2002	EP1000035B1 Substituted 6-phenylphenanthridines
11/27/2002	EP0585267B1 Herpesvirus particle preparation and vaccine
11/27/2002	CN1382144A Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002	CN1382138A Piperidine derivatives as reuptake inhibitors
11/27/2002	CN1382137A Thtrahydrothiopy 2,3-diazanaphthylaone derivatives as PDE inhibitors
11/27/2002	CN1382135A Amine and amide derivatives as ligands for neuropeptide YY5 receptor usefu in treatment of obesity and other disorders
11/27/2002	CN1382124A Bicycle androgen and progesterone receptor modulator compounds and methods
11/27/2002	CN1382121A C16 unsaturated FP-selective prostaglandins analogs
11/27/2002	CN1382118A Biocyclic amino acids aspharmaceutical agents
11/27/2002	CN1382060A Dosages for treatment with anti-ErbB2 antibodies
11/27/2002	CN1382054A Novel contraceptive medicament and method for producing the same
11/27/2002	CN1382053A Novel hormonal composition and use thereof
11/27/2002	CN1381556A Xingshi wine-for tonifying kidney and strengthening yang
11/27/2002	CN1381456A Pyrimidine-4-keto compound, its preparation method and medicine composition containing them
11/27/2002	CN1381273A Vaginal-applied interferon table and its preparing process
11/27/2002	CN1381249A Chinese patent medicine for treating venereal disease and puzzle dermatopathy
11/27/2002	CN1381248A Chinese patent medicine for treating venereal disease

1 ... 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 ... 557